AU2001282010A1 - Pharmaceutical composition comprising metformin and a 5-phenoxyalkyl-2,4-thiazolidinedione-type derivative - Google Patents

Pharmaceutical composition comprising metformin and a 5-phenoxyalkyl-2,4-thiazolidinedione-type derivative

Info

Publication number
AU2001282010A1
AU2001282010A1 AU2001282010A AU8201001A AU2001282010A1 AU 2001282010 A1 AU2001282010 A1 AU 2001282010A1 AU 2001282010 A AU2001282010 A AU 2001282010A AU 8201001 A AU8201001 A AU 8201001A AU 2001282010 A1 AU2001282010 A1 AU 2001282010A1
Authority
AU
Australia
Prior art keywords
thiazolidine
dione
ethyl
metformin
fluorophenoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001282010A
Other languages
English (en)
Inventor
Gerard Botton
Didier Mesangeau
Gerard Moinet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU2001282010A1 publication Critical patent/AU2001282010A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001282010A 2000-08-04 2001-07-24 Pharmaceutical composition comprising metformin and a 5-phenoxyalkyl-2,4-thiazolidinedione-type derivative Abandoned AU2001282010A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0010362 2000-08-04
FR0010362A FR2812547B1 (fr) 2000-08-04 2000-08-04 Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
PCT/EP2001/008512 WO2002011721A1 (en) 2000-08-04 2001-07-24 Pharmaceutical composition comprising metformin and a 5-phenoxyalkyl-2,4-thiazolidinedione-type derivative

Publications (1)

Publication Number Publication Date
AU2001282010A1 true AU2001282010A1 (en) 2002-02-18

Family

ID=8853342

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001282010A Abandoned AU2001282010A1 (en) 2000-08-04 2001-07-24 Pharmaceutical composition comprising metformin and a 5-phenoxyalkyl-2,4-thiazolidinedione-type derivative

Country Status (19)

Country Link
US (1) US20040014797A1 (pt)
EP (1) EP1305025A1 (pt)
JP (1) JP2004505915A (pt)
KR (1) KR20030019470A (pt)
CN (1) CN1446090A (pt)
AR (1) AR030309A1 (pt)
AU (1) AU2001282010A1 (pt)
BR (1) BR0112915A (pt)
CA (1) CA2417883A1 (pt)
CZ (1) CZ2003476A3 (pt)
EC (1) ECSP034463A (pt)
FR (1) FR2812547B1 (pt)
HU (1) HUP0303684A2 (pt)
MX (1) MXPA03000975A (pt)
NO (1) NO20030518L (pt)
PL (1) PL358791A1 (pt)
RU (1) RU2003105809A (pt)
SK (1) SK2082003A3 (pt)
WO (1) WO2002011721A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003105809A1 (en) 2002-06-17 2003-12-24 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
UA80991C2 (en) * 2002-10-07 2007-11-26 Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
US20090325860A1 (en) * 2006-08-04 2009-12-31 Nastech Pharmaceutical Company Inc. Compositions for intranasal delivery of human insulin and uses thereof
WO2008093984A1 (en) 2007-01-29 2008-08-07 Hanall Pharmaceutical Company. Ltd N, n- dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2749583B1 (fr) * 1996-06-07 1998-08-21 Lipha Nouveaux derives de thiazolidine -2,4- dione substitues, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
DE122007000054I1 (de) * 1997-06-18 2007-12-13 Smithkline Beecham Plc Behandlung der Diabetes mit Thiazolidindione und metformin
GB9715295D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment

Also Published As

Publication number Publication date
NO20030518D0 (no) 2003-02-03
KR20030019470A (ko) 2003-03-06
SK2082003A3 (en) 2003-07-01
CZ2003476A3 (cs) 2003-06-18
AR030309A1 (es) 2003-08-20
FR2812547A1 (fr) 2002-02-08
RU2003105809A (ru) 2004-08-27
NO20030518L (no) 2003-02-03
HUP0303684A2 (hu) 2004-03-01
PL358791A1 (en) 2004-08-23
CA2417883A1 (en) 2002-02-14
ECSP034463A (es) 2003-03-31
EP1305025A1 (en) 2003-05-02
US20040014797A1 (en) 2004-01-22
BR0112915A (pt) 2003-07-08
JP2004505915A (ja) 2004-02-26
FR2812547B1 (fr) 2002-10-31
CN1446090A (zh) 2003-10-01
WO2002011721A1 (en) 2002-02-14
MXPA03000975A (es) 2003-06-09

Similar Documents

Publication Publication Date Title
CA2320039C (en) Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia
JP4011114B2 (ja) 脳浮腫抑制剤
JPH0372463A (ja) 腎機能改善剤
WO2007007757A1 (ja) PPARγアゴニストを含有する医薬組成物
US20040014797A1 (en) Pharmaceutical composition comprising metformin and a 5-phenoxyalkyl-2,4-thiazolidinedione-type derivative
EP1448181B1 (en) Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes
WO2003047627A1 (en) Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a thiazolidinedione derivative, and a use thereof for treating diabetes
US20050176787A1 (en) Thiazolidinediones alone or in combination with other therapeutic agents for inhibiting or reducing tumour growth
WO2003041706A1 (en) Pharmaceutical composition comprising a glitazone and a thiazolidinedione derivative, and use thereof for treating diabetes
US20040097567A1 (en) Pharmaceutical composition
AU2002247755A1 (en) Pharmaceutical composition for the treatment of diabetes comprising a 5-phenoxyalkal-2,4-thiazolidinedione derivative and a compound that stimulates insulin secretion
EP0334674A2 (en) Use of isoxazolinones as cerebro-active drugs
WO2003047574A1 (en) Pharmaceutical composition comprising a derivative of 5-phenoxyalkyl-2,4-thiazolidinedione type and a 4-oxobutanoic acid
US20050085489A1 (en) Pharmaceutical composition comprising a glitazone and a 4-oxobutanoic acid, and the use thereof for treating diabetes
WO2003092726A1 (en) Combination of insulin and a thiazolidinedione derivative, and use thereof for treating diabetes
JP2005513149A (ja) α−グルコシダーゼ阻害剤及び４−オキソブタン酸を含む薬剤組成物並びにその糖尿病治療への使用
WO2004028537A1 (en) Use of thiazolidinedione derivatives as aldose reductase inhibitors
WO2005117853A1 (ja) 高脂血症治療剤及び糖尿病治療剤